2013-09-10 13:46:49 - New Pharmaceuticals market report from MarketLine: "Generics in the United States"
Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United States generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
* For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to
be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
* The US generics market had total revenues of $73.6bn in 2012, representing a compound annual growth rate (CAGR) of 5.2% between 2008 and 2012.
* Market consumption volume increased with a CAGR of 4% between 2008-2012, to reach a total of 84% of total pharma volume in 2012.
* The performance of the market is forecast to accelerate, with an anticipated CAGR of 6% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $98.7bn by the end of 2017.
Full Report Details at
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in the United States
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in the United States
Leading company profiles reveal details of key generics market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the United States generics market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the United States economy
Key Questions Answered
What was the size of the United States generics market by value in 2012?
What will be the size of the United States generics market in 2017?
What factors are affecting the strength of competition in the United States generics market?
How has the market performed over the last five years?
What are the main segments that make up the United States's generics market?
Partial Table of Contents:
TABLE OF CONTENTS
Market value forecast
Market volume forecast
Market value forecast
Market volume forecast
Five Forces Analysis
Threat of substitutes
Degree of rivalry
Sandoz International GmbH
Teva Pharmaceutical Industries Limited
Related MarketLine research
LIST OF TABLES
Table 1: United States generics market value: $ million, 2008-12
Table 2: United States generics market volume: % of total pharma volume, 2008-12
Table 3: United States generics market geography segmentation: $ million, 2012
Table 4: United States generics market value forecast: $ million, 2012-17
Table 5: United States generics market volume forecast: % of total pharma volume, 2012-17
Table 6: Actavis, Inc.: key facts
Table 7: Actavis, Inc.: key financials ($)
Table 8: Actavis, Inc.: key financial ratios
Table 9: Mylan Inc.: key facts
Table 10: Mylan Inc.: key financials ($)
Table 11: Mylan Inc.: key financial ratios
Table 12: Sandoz International GmbH: key facts
Table 13: Teva Pharmaceutical Industries Limited: key facts
Table 14: Teva Pharmaceutical Industries Limited: key financials ($)
Table 15: Teva Pharmaceutical Industries Limited: key financial ratios
Table 16: United States size of population (million), 2008-12
Table 17: United States gdp (constant 2000 prices, $ billion), 2008-12
Table 18: United States gdp (current prices, $ billion), 2008-12
Table 19: United States inflation, 2008-12
Table 20: United States consumer price index (absolute), 2008-12
Table 21: United States exchange rate, 2008-12
LIST OF FIGURES
Figure 1: United States generics market value: $ million, 2008-12
Figure 2: United States generics market volume: % of total pharma volume, 2008-12
Figure 3: United States generics market geography segmentation: % share, by value, 2012
Figure 4: United States generics market value forecast: $ million, 2012-17
Figure 5: United States generics market volume forecast: % of total pharma volume, 2012-17
Figure 6: Forces driving competition in the generics market in the United States, 2012
Figure 7: Drivers of buyer power in the generics market in the United States, 2012
Figure 8: Drivers of supplier power in the generics market in the United States, 2012
Figure 9: Factors influencing the likelihood of new entrants in the generics market in the United States, 2012
Figure 10: Factors influencing the threat of substitutes in the generics market in the United States, 2012
Figure 11: Drivers of degree of rivalry in the generics market in the United States, 2012
Figure 12: Actavis, Inc.: revenues & profitability
Figure 13: Actavis, Inc.: assets & liabilities
Figure 14: Mylan Inc.: revenues & profitability
Figure 15: Mylan Inc.: assets & liabilities
Full Table of Contents is available at:
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.